Point72 Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-62,432
Closed -$25.7M 2208
2024
Q2
$25.7M Buy
+62,432
New +$24.7M 0.07% 340
2023
Q4
Sell
-146,101
Closed -$35.4M 2547
2023
Q3
$35.4M Buy
146,101
+144,381
+8,394% +$36.9M 0.1% 259
2023
Q2
$413K Buy
+1,720
New +$357K ﹤0.01% 1297
2021
Q3
Sell
-75,951
Closed -$13.4M 1156
2021
Q2
$13.4M Sell
75,951
-37,439
-33% -$6.46M 0.06% 380
2021
Q1
$18.6M Buy
113,390
+54,751
+93% +$8.37M 0.09% 279
2020
Q4
$8.16M Sell
58,639
-61,222
-51% -$7.72M 0.04% 486
2020
Q3
$13.4M Buy
+119,861
New +$13.9M 0.07% 347
2019
Q2
Sell
-8,433
Closed -$497K 1458
2019
Q1
$497K Buy
+8,433
New +$504K ﹤0.01% 867
2018
Q4
Sell
-18,033
Closed -$1.08M 1119
2018
Q3
$1.08M Sell
18,033
-23,467
-57% -$1.28M ﹤0.01% 843
2018
Q2
$1.78M Buy
+41,500
New +$1.68M 0.01% 764
2017
Q3
Sell
-154,400
Closed -$4.48M 980
2017
Q2
$4.48M Buy
+154,400
New +$4.33M 0.03% 525

Other funds holding MEDP

Point72 Asset Management's MEDP Position: Q3 2024 in Review

Point72 Asset Management sold out of Medpace (MEDP) in Q3 2024, closing a stake of 62,432 shares — an estimated $25.7M sold.

Point72 Asset Management first reported a position in MEDP in Q2 2017 and held it in 11 quarters. The position peaked at $35.4M in Q3 2023. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Point72 Asset Management reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Point72 Asset Management sold 62,432 Medpace shares in Q3 2024, an estimated $25.7M.
  • Point72 Asset Management first reported a position in Medpace in Q2 2017 and held it in 11 quarters.
  • Point72 Asset Management's Medpace position peaked at $35.4M in Q3 2023.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.